Ronald Menezes Biography and Net Worth

Ron Menezes joined Sientra in November 2020 as President and Chief Executive Officer. Ron’s most recent experience includes serving as President and General Manager for Almirall U.S. – Dermatology, where he led exceptional growth and profitability improvements, returning the U.S. division to profitability. Ron was also part of the team that successfully acquired Allergan’s dermatology assets in 2018. In 2019, he led the launch of a new molecule for the treatment of acne that far exceeded revenue goals by strategically focusing on improving patients’ access to the product. Prior to Almirall, Ron was the Vice President of Sales and Marketing for Dermatology at Allergan, leading the team to more than 20% yearly growth between 2013 and 2015. The growth was driven by increased direct-to-consumer advertising and expanding the promotion of a 20-year-old topical product for acne. As a head of sales for SkinMedica, Latisse and Medical Dermatology, Ron was part of the commercial team that successfully launched a new direct-to-physician sunscreen product. While at SkinMedica, he focused on expanding national accounts that were responsible for driving most of the growth in 2015. Ron has also held key leadership responsibilities at Abbott, Astellas Pharma – U.S., Pfizer and Eli Lilly. Ron holds a B.S. in International Business from Brigham Young University and earned a certificate in Health Care Management from the University of Utah.